Breast cancer
Results
Phase 3
This trial looked at a Cox-2 inhibitor called celecoxib to see if it stopped early breast cancer coming back. It was open to women who had all of the following:
breast surgery
further treatment after surgery
breast cancer that didn’t have a large number of the HER2 receptor (HER2 negative breast cancer)
This trial was open for people to join between 2007 and 2012. The team published the results in 2021.
Cancer Research UK supported this trial.
Recruitment start: 19 January 2007
Recruitment end: 1 October 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Charles Coombes
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
German Breast Group (GBG)
Imperial College London
NIHR Clinical Research Network: Cancer
Pfizer
This is Cancer Research UK trial number CRUKE/03/015.
Last reviewed: 21 September 2021
CRUK internal database number: 464
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
